Rapport Therapeutics Inc (RAPP)

Rapport Therapeutics, Inc. is a leading biotechnology firm focused on developing innovative therapeutics for neurodegenerative diseases, particularly Alzheimer's disease and related cognitive disorders. Leveraging proprietary drug candidates and advanced technology platforms, the company is committed to addressing critical unmet medical needs through rigorous scientific research and clinical development. With a strong pipeline of therapeutic solutions, Rapport Therapeutics is uniquely positioned to influence the treatment landscape for patients suffering from debilitating cognitive impairments, thereby enhancing their quality of life.